Please read our privacy policy before using our website. If you continue to use our website, you imply acceptance of the data privacy declaration.
“AGIT II – Software support for clinical trials” (Congress Center Hamburg, May 16th, 3 PM – 4.30 PM) Systematics, efficiency, flexibility: With mint Lesion™ 2.0, we created a solution that supports established evaluation criteria in every detail and furthermore, can be adapted for specific trial…
Institute for clinical trials and imaging diagnostics in drug and medical device development installs CHILI PACS with mint Lesion™ The Clinical Research Institute clinstud implemented a software package consisting of CHILI PACS and mint Lesion™ for the quantitative analysis of image data (MRI, CT, PET)…
86% of radiologists would like to increase tumor measurements – we show how A survey in the American Journal of Radiology (issue 195:101-106) depicts today’s challenges in oncological therapy monitoring: Almost all of the approximately 300 participating radiologists confirmed the high importance of tumor measurement…
1 year successful application of mint Lesion™ at the University Hospital Essen Since more than one year, the Institute of Diagnostic and Interventional Radiology and Neuroradiology at the University Hospital Essen is using a thin-client installation of mint Lesion™ to increase their quality and efficiency…
University Hospital Munich: Excellent quality and efficiency in oncological radiology due to mint Lesion™ The institute of clinical radiology at the Ludwig-Maximilians-University Munich relies on mint Lesion™ for an efficient performance of oncological therapy monitoring on a highest quality level. In particular, the comprehensive support…
November Personalized cancer therapy – accentuate quality and impact of your oncological radiological services with mint Lesion™ 2.2 September Hannover Medical School and Mint Medical enter into R&D cooperation to improve the response evaluation of HCC tumors Mint Medical cooperates with syneed medidata GmbH in…
mint Lesion™ technology receives FDA 510(k) clearance and is now widely available to the North American market mint Lesion™, distributed by Translational Sciences Corp. (TSC) in the United States under the brand name OncoTrac™, has received 510(k) clearance from the U. S. Food and Drug…
Mint Medical and the research network QUINO (Quantitative Imaging in Oncology) are funded by the Federal Ministry for Education and Research (BMBF) Mint Medical was selected for an initiative to promote innovation and research in Germany, funded by the federal government under the leadership of…
University Hospital Basel, Switzerland, adopts mint Lesion™ in oncological radiology The hospital uses a thin-client installation of mint Lesion™ to raise quality in radiological oncology through quantitative image analysis – both within clinical trials and in the daily clinical routine. In 1897, the Basel Institute…
mint Lesion™ 1.8 Announcement: Dedicated workflows to manage lymphoma patients in trials and clinical routine In time for RSNA 2011 Mint Medical GmbH announced the new mint Lesion™ 1.8. This feature release puts strong focus on the assessment of lymphoma patients. It comes with elaborate…
